Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Genichiro Sotodate und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Iwate Medical University, Yahaba, Japan. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Glycoproteins, Umbilical Arteries, Fetal Blood. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Morinaga Foundation for Health & Nutrition; JSPS KAKENHI, Morinaga Foundation For Health and Nutrition.
Themen: Neonatologie
Abstract (Originalsprache)
Introduction
Leucine‐rich α‐2 glycoprotein (LRG) is an acute‐phase reactant protein which reflects inflammation differently from C‐reactive protein. We investigated the value of cord blood LRG levels for predicting bronchopulmonary dysplasia (BPD) in preterm infants.
Methods
This prospective cohort study included 64 infants born at 22–31 weeks' gestation (22 and 42 in the BPD and non‐BPD arms, respectively), and between‐group comparisons of LRG and interleukin (IL)‐6 levels in the cord blood, neonatal LRG, and immunoglobulin (Ig)M were undertaken. Accounting for gestational age, inverse probability weighted generalized estimating equation assessed the biomarkers' independent effects on BPD.
Results
In the BPD group, the incidences of histological chorioamnionitis, funisitis, neonatal steroid treatment, and ventilator duration were significantly higher ( p = 0.023, 0.043, 0.011, and < 0.001, respectively) whereas the Apgar score 1st minute, 5th minute, birthweight, and gestational age were significantly lower ( p = 0.001, 0.011, < 0.001, < 0.001, respectively). After adjustment, umbilical artery (UA)‐LRG (odds ratio [OR]: 2.678, 95% confidence interval [CI]: 1.225–0.5.857; p = 0.014) and umbilical vein (UV)‐IL‐6 (OR: 1.258, 95% CI: 1.020–1.552; p = 0.032) remained independent risk factors for BPD, whereas UV‐LRG, UA‐IL‐6, IgM, and neonatal‐LRG showed no significant associations.
Conclusions
UA‐LRG may serve as a biomarker for predicting BPD and identify infants who are at a higher risk of BPD and could benefit more from corticosteroids or other therapies. UA‐LRG's superior predictive accuracy over UV‐LRG is attributable to the fact that cytokines in the amniotic fluid might cause fetal inflammation in utero before the development of histologically chorioamnionitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Iwate Medical University, Yahaba, Japan.
- Institute for Biomedical Science, Molecular Pathophysiology, Iwate Medical University, Yahaba, Japan.
- Department of Information Science, Iwate Medical University, Yahaba, Japan.
- Division of Allergy and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.
ORCID-Profile: Genichiro Sotodate
Förderung
- Morinaga Foundation for Health & Nutrition; JSPS KAKENHI
- Morinaga Foundation For Health and Nutrition
Zitieren
APA
Sotodate, G., Serada, S., Takahashi, F., Matsumoto, A., Toya, Y., Tsuchiya, S., Fujimoto, M., Naka, T., & Akasaka, M. (2025). Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71425
Vancouver
Sotodate G, Serada S, Takahashi F, Matsumoto A, Toya Y, Tsuchiya S, et al. Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71425
BibTeX
@article{Sotodate2025,
author = {Sotodate, Genichiro and Serada, Satoshi and Takahashi, Fumiaki and Matsumoto, Atsushi and Toya, Yukiko and Tsuchiya, Shigekuni and Fujimoto, Minoru and Naka, Tetsuji and Akasaka, Manami},
title = {Umbilical Artery Leucine‐Rich α‐2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71425}
}
EUVIMED